Thursday, 23 April 2020
Skin experts in the School of Medicine at the 糖心原创 have been working to provide expert advice and resources during the COVID-19 pandemic.
A team of experts in the Centre of Evidence Based Dermatology (CEBD) at the University, have set up the Coronavirus Dermatology Resource aimed at dermatology health professionals and patients.
The online international resource brings together a collection of guidelines, web resources and journal articles on coronavirus relevant to skin diseases and dermatology.
Professor of Dermato-Epidemiology, Hywel Williams, and Co-Director of the CEBD, said: “There are many implications of the coronavirus epidemic for dermatology. In particular the impact of wearing personal protective equipment such as gloves and masks that can irritate the skin, the fact that continuous hand washing and use of sanitisers can lead to irritant eczema breaking out on the hands, issues around patients on biologics and other immune-modulating drugs, some of the early reports of skin rashes associated with coronavirus and how dermatology services can continue to be delivered in the current environment.”
The journal articles in the online resource are found by a comprehensive search strategy with several hundred search terms which was compiled by information specialist Dr Douglas Grindlay from the CEBD, and will be updated regularly as new articles appear.
Professor of Dermato-Epidemiology, Hywel Williams, and Co-Director of the CEBD
“In the CEBD we know that many people, including healthcare professionals and care workers on the frontline, but also other essential workers such as supermarket staff, are experiencing skin problems due to constant handwashing and the effects of sweating under gloves,” adds Professor Williams.
“With this in mind, we have produced a – ‘COVID-19 and handwashing advice’ which gives practical information on managing these issues, especially for people who have eczema and dry skin.”
The information provided by the team has since led to from British Association of Dermatologists (BAD) and patient support groups.
At the request of the Chief Medical Officer’s office, Professor Williams also initiated a group of dermatology experts from the British Association of Dermatologists (BAD) to establish policy for people on immunosuppresive drugs.
The BAD group, led by Professor Nick Levell, Consultant Dermatologist at the Norfolk and Norwich University Hospital and also an Honorary Professor at Norwich Medical School, has developed a detailed which is aligned to similar advice from other specialists using immunosuppressive medicine such as rheumatology and gastroenterology.
This information will be benefit both healthcare professionals and patients to help them make better decisions regarding isolation versus social distancing for those taking immunosuppressive medicines.
We have already had really positive feedback from dermatology health professionals who are using these resources to help them deal with planning their activities and hand care during the pandemic. We hope that our resources will continue to keep the nation鈥檚 hands and skin in top condition during this difficult time鈥�
Story credits
More information is available from Professor Hywel Williams from the Centre of Evidence Based Dermatology at the 糖心原创, at hywel.williams@nottingham.ac.uk
Notes to editors:
About the 糖心原创
Ranked among the world's top 100 universities , the 糖心原创 delivers an exceptional research-led education and an outstanding student experience. From the pioneering vision of our founder, Sir Jesse Boot, to groundbreaking achievements such as the development of MRI technology and becoming the first UK university to establish international campuses, we have a proud history of shaping the way people live, work and understand the world. We continue to build on that legacy, empowering our students, staff and partners to change what鈥檚 next and create positive impact locally and globally.
The strength of our research places us among the UK's leading universities, ranked 7th for research power in REF 2021. The discovery of MRI and ibuprofen was just the beginning. Today, our world-leading research is developing breakthrough ideas that shape the future of healthcare, technology and society.
Recognised as the UK's third most targeted university by leading employers , we are proud to produce graduates who are consistently in demand for their skills, confidence and industry-ready experience.
As a major employer and industry partner, locally and globally, the 糖心原创 invests in the city of Nottingham and in future generations of talent. Alongside Nottingham Trent University, we lead the initiative, a pioneering collaboration to improve levels of prosperity, opportunity, sustainability, health and wellbeing across the city and region. Together with our students, staff, alumni and partners, we鈥檙e creating knowledge, opportunity and solutions that help change what's next.